Maple qNMR peptide purity analysis measures how much peptide is actually present as a fraction of total sample mass, rather than as a relative percentage of chromatographic peak area. That distinction is not academic. A vial can return a 98 percent HPLC purity figure and still contain substantially less than 98 percent peptide by weight, because reversed-phase chromatography with ultraviolet detection cannot see what does not absorb ultraviolet light. Published quantitative NMR analyses of commercially sourced synthetic peptides have found undeclared excipient making up as much as 43 percent of sample mass in material shipped with certificates declaring high chromatographic purity.
Every analytical method used to certify a research peptide answers a specific question, and the question HPLC answers is narrower than most buyers assume. Understanding where quantitative nuclear magnetic resonance fits alongside chromatography, mass spectrometry, and amino acid analysis is the difference between reading a certificate and understanding one.
What qNMR Measures That HPLC Area Percent Cannot
Reversed-phase HPLC separates components of a sample and reports each as a percentage of total detected peak area. The number that appears on most peptide certificates of analysis is exactly that: a ratio of the target peptide peak to all other peaks the detector registered. The method is sensitive, reproducible, and excellent at resolving peptide-related impurities such as truncation sequences and deletion products, which share the parent chromophore and therefore respond to the same detector.
The limitation is structural rather than a matter of instrument quality. Ultraviolet detection at 214 nanometres responds to the peptide bond, and at 280 nanometres to aromatic side chains. Substances lacking those features are effectively invisible. Residual water, inorganic salts, silica carried over from purification, many sugars and sugar alcohols, and a range of process solvents pass through the detector without generating signal, or elute in the void volume where they are excluded from integration entirely. None of them reduce the reported area percent, yet all of them occupy mass in the vial.
Quantitative NMR operates on a fundamentally different principle. Signal intensity in a proton NMR spectrum is directly proportional to the number of nuclei producing it, which makes qNMR a primary ratio method in the metrological sense, comparable to gravimetry and coulometry. When a sample is measured against a certified internal standard of known purity, the resulting figure is an absolute mass fraction traceable to SI units. It does not describe how the peptide compares to its chromatographic neighbours. It describes how much peptide is in the material.
Key Research Findings
- Choules, Bisson, Simmler, McAlpine, Giancaspro, Bzhelyansky, Niemitz and Pauli, writing in the Journal of Pharmaceutical and Biomedical Analysis in 2020 (volume 178, article 112915), found mannitol present at 20 percent and 43 percent w/w as an undeclared constituent in two commercially sourced custom synthetic peptides designated DR and DRVYI.
- In that same work, quantitative proton NMR detected and quantified the mannitol on a 60 MHz benchtop instrument, not solely on high-field hardware, and quantum-mechanical iterative full spin analysis independently confirmed both the identity of the adulterant and the quantitative result.
- Melanson, Thibeault, Stocks, Leek, McRae and Meija, in Analytical and Bioanalytical Chemistry in 2018, assigned a purity value of 691 ± 9 mg/g (k = 2) to a candidate angiotensin II certified reference material, combining qNMR, LC-MS/MS amino acid analysis and mass balance through a Bayesian statistical framework.
- In that angiotensin II material, trifluoroacetic acid counterion accounted for nearly 25 percent of total mass, measured by a validated fluorine-19 qNMR method.
- Choules and colleagues, in the Journal of Organic Chemistry in 2019 (volume 84, issue 6, pages 3055 to 3073), demonstrated NMR-based peptide sequencing on aspartame, glutathione, the octapeptide angiotensin II and the nonapeptide oxytocin, concluding that qNMR can confirm identity and absolute purity in a single measurement.
- Synthetic oxytocin was selected as the test material for CCQM-K115.b, an international key comparison on peptide purity coordinated through the Consultative Committee for Amount of Substance at the International Bureau of Weights and Measures.
The Mannitol Case: When a Certificate Says 98 Percent and the Vial Is Not
The 2020 Choules study is the most direct published illustration of the gap between chromatographic purity and material reality. The group obtained two custom synthetic peptides from a commercial supplier, both accompanied by certificates of analysis reporting high HPLC purity. Routine proton NMR, run as a confirmatory identity check rather than as an investigation, produced signals that did not belong to either peptide sequence.
The unexpected resonances were mannitol, a sugar alcohol commonly used as a bulking agent in freeze-dried formulations. It was present at 20 percent w/w in one sample and 43 percent w/w in the other. Neither certificate declared it. In the second sample, well over a third of the powder in the vial was not peptide at all.
Why Reversed-Phase HPLC Missed It
Mannitol has no chromophore. It contains no aromatic ring and no peptide bond, so it generates essentially no signal at the ultraviolet wavelengths used for peptide detection. It is also extremely polar, meaning that on a C18 column under standard aqueous-organic gradient conditions it has minimal retention and elutes at or near the void volume, a region routinely excluded from integration because it contains the injection disturbance and unretained sample matrix.
The result is a chromatogram in which mannitol is doubly absent: undetected by the detector and, even had it been detected, positioned where analysts do not integrate. The area percent calculation is performed on what remains, and what remains is peptide and peptide-related impurities. The arithmetic is correct. The conclusion a reader draws from it is not.
This is the same class of blind spot that makes counterion content a recurring issue in peptide certification. Trifluoroacetic acid, used almost universally as an ion-pairing agent in preparative peptide purification, remains bound to basic residues in the lyophilised product and can represent a substantial mass fraction without appearing in any chromatographic purity figure. We have covered that problem separately in our analysis of residual TFA and counterion content in research peptides.
Absolute Purity Assignment in Certified Reference Materials
The angiotensin II work by Melanson and colleagues shows what rigorous absolute purity assignment actually requires, and it is instructive precisely because the material in question was a candidate certified reference material prepared under metrological conditions rather than a commodity research product.
Three independent approaches were applied. LC-MS/MS amino acid analysis quantified the peptide following hydrolysis. Proton qNMR quantified the intact peptide directly, avoiding the hydrolysis efficiency corrections that amino acid analysis requires. A mass balance approach summed the non-peptide components, with fluorine-19 qNMR used to measure the TFA counterion, which turned out to account for close to a quarter of the sample by mass. The three results were reconciled using a Bayesian framework that treated mass balance as prior knowledge.
The final assigned value was 691 ± 9 mg/g at a coverage factor of 2. In plain terms, a carefully prepared reference-grade angiotensin II material was 69.1 percent peptide by mass, with an expanded uncertainty of under 1 percent. The remaining 30 percent was counterion, water and residual process components. A chromatographic purity figure for the same material would have been far higher, and would not have been wrong; it would simply have been answering a different question.
The methodological point generalises. Absolute content and chromatographic purity are separate quantities, and no amount of precision in one substitutes for the other. This is the same reasoning that underlies amino acid analysis and net peptide content determination, which remains the more common orthogonal check in routine peptide quality control.
Benchtop Instrumentation Changes the Accessibility Calculation
The standard objection to qNMR in a quality control context is cost. High-field spectrometers at 400 MHz and above require substantial capital investment, cryogen supply, shielded space and specialist operators, which places them outside the reach of most contract testing laboratories serving the research peptide market.
The 2020 mannitol finding complicates that objection. The contaminant was detected and quantified on a 60 MHz benchtop instrument, a class of hardware that is permanent-magnet based, requires no cryogens, occupies bench space rather than a dedicated room, and costs a fraction of a superconducting system. Gross adulteration at the tens-of-percent level produces signals that do not require high field strength to resolve. A benchtop instrument will not deliver a metrologically traceable absolute purity assignment on a complex peptide, but it will readily answer the question of whether a substantial mass fraction of the vial is something other than peptide.
The 2019 Journal of Organic Chemistry work by the same group reached a related conclusion, noting that because qNMR confirms identity and absolute purity in a single measurement, NMR is a plausible candidate for adoption in peptide manufacturing quality control rather than remaining a research-laboratory technique.
Where qNMR Falls Short
qNMR is not a replacement for chromatography, and treating it as one would be a different kind of error. Its central weakness is spectral overlap. A peptide of thirty or forty residues produces hundreds of proton resonances crowded into a narrow chemical shift range, and resolving a specific integrable signal free of interference becomes progressively harder as sequence length increases. The published demonstrations of peptide qNMR have concentrated on small peptides for exactly this reason: aspartame is a dipeptide, glutathione a tripeptide, angiotensin II an octapeptide, oxytocin a nonapeptide.
qNMR also has poor sensitivity to low-level related impurities. A truncation sequence present at 0.3 percent produces resonances buried in the noise and largely coincident with the parent peptide’s own signals, whereas the same impurity is straightforward to resolve and integrate by HPLC or to identify by mass spectrometry. Sample throughput is lower, deuterated solvent adds per-sample cost, and the internal standard itself must be a certified material with its own assigned purity and uncertainty.
The honest summary is that qNMR and HPLC fail in opposite directions. HPLC resolves peptide-related impurities well and non-chromophoric mass poorly. qNMR quantifies total non-peptide mass well and low-level peptide-related impurities poorly. Neither is redundant.
How Orthogonal Methods Fit Together
A defensible purity picture for a research peptide comes from methods that fail differently. HPLC establishes chromatographic purity and resolves peptide-related impurities. Mass spectrometry confirms molecular identity and characterises those impurities structurally. Karl Fischer analysis quantifies water. Gas chromatography headspace analysis quantifies residual process solvents. Amino acid analysis or qNMR establishes how much peptide is present in absolute terms. Capillary electrophoresis adds charge-based separation that resolves deamidation products chromatography frequently co-elutes.
The value of this layered approach is that each method’s blind spot is another method’s strength. Mannitol at 43 percent w/w is invisible to reversed-phase HPLC and unmistakable by qNMR. A 0.4 percent deamidated variant is invisible by qNMR and resolvable by capillary electrophoresis. A certificate reporting a single HPLC number is not fraudulent, but it is a partial answer presented in a format that reads like a complete one.
What This Means for Evaluating a Research Peptide Supplier
The practical implication is not that researchers should demand qNMR data, which almost no supplier in this market can currently provide. It is that a purity percentage should be read as method-specific rather than absolute, and that the methods listed on a certificate matter as much as the number.
Useful questions to put to any supplier include which specific method generated the reported purity figure, whether water content and counterion content were determined separately, whether any bulking agent or excipient was added after purification, and whether the analysis was performed by an independent laboratory or in-house. A certificate that reports HPLC purity alongside water determination and counterion content describes a material far more completely than one reporting a single chromatographic figure, even when that figure is higher.
Maple Research Labs publishes third-party analytical documentation from Janoshik Analytical for tested product batches, and those reports are available on our certificates of analysis page so that reported figures can be checked against the underlying chromatograms rather than taken on assertion. Batch documentation for compounds such as BPC-157 is linked directly from the relevant product listing.
The broader lesson from the mannitol case is worth stating plainly. Two researchers ordered peptides, received certificates showing high purity, and would have proceeded on the assumption that they were weighing out peptide. A confirmatory NMR run, performed as routine practice rather than out of suspicion, showed that a large fraction of what they had weighed was sugar alcohol. Any concentration calculated from that mass would have been wrong by tens of percent, and every downstream result would have inherited the error.
For research purposes only. Not for human consumption. Not for diagnostic or therapeutic use.
Want more research like this?
Weekly peptide study breakdowns. No spam. Unsubscribe anytime.